SOD1 and amyotrophic lateral sclerosis: Rouaux and colleagues demonstrated that sodium valproate (250 mg/kg/day), an inhibitor of HDACs, slightly prevented MNs degeneration and improved motor functions in the SOD1(G86R) mouse model of ALS, showing a delay of onset of 10% compared to untreated once but without improving mean survival25.